『Switching from Aflibercept to Faricimab in Wet AMD Patients』のカバーアート

Switching from Aflibercept to Faricimab in Wet AMD Patients

Switching from Aflibercept to Faricimab in Wet AMD Patients

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

 Does switching wet AMD patients from aflibercept (Eylea, Regeneron) to faricimab (Vabysmo, Genentech) improve disease outcomes? Join Ben Young, MD, MS, and his guests Lediana Goduni, MD, and Joshua Uhr, MD, as they explore this a recent peer review paper on this question. What are the potential benefits of such a switch? How should providers use findings such as these to inform their practice? And are significant improvements in anatomy relevant if vision gains are unchanged?

Switching from Aflibercept to Faricimab in Wet AMD Patientsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。